Hedge Fund - Chou Associates Management
Sanofi Aventis (SNY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2021 - Q2 (2021-06-30) | $0 | 0% | 0 | $52.18 |
| 2 | 2020 - Q2 (2020-06-30) | $0 | 0% | 0 | $48.60 |
| 3 | 2020 - Q1 (2020-03-31) | $874,000 | 0.87% | 20,000 | $47.85 |
| 4 | 2019 - Q4 (2019-12-31) | $1,004,000 | 0.57% | 20,000 | $46.85 |
| 5 | 2019 - Q3 (2019-09-30) | $927,000 | 0.56% | 20,000 | $43.13 |
| 6 | 2019 - Q2 (2019-06-30) | $865,000 | 0.4% | 20,000 | $42.52 |
| 7 | 2019 - Q1 (2019-03-31) | $10,976,000 | 4.65% | 248,000 | $42.83 |
| 8 | 2018 - Q4 (2018-12-31) | $12,936,000 | 5.8% | 298,000 | $44.10 |
| 9 | 2018 - Q3 (2018-09-30) | $16,081,000 | 5.4% | 360,000 | $42.72 |
| 10 | 2018 - Q2 (2018-06-30) | $16,404,000 | 6.21% | 410,000 | $39.37 |
| 11 | 2018 - Q1 (2018-03-31) | $16,433,000 | 6.92% | 410,000 | $41.61 |
| 12 | 2017 - Q4 (2017-12-31) | $17,630,000 | 7.54% | 410,000 | $46.11 |
| 13 | 2017 - Q3 (2017-09-30) | $20,414,000 | 7.13% | 410,000 | $48.39 |
| 14 | 2017 - Q2 (2017-06-30) | $19,717,000 | 6.08% | 410,000 | $47.79 |
| 15 | 2017 - Q1 (2017-03-31) | $18,553,000 | 6.15% | 410,000 | $42.42 |
| 16 | 2016 - Q4 (2016-12-31) | $16,580,000 | 5.3% | 410,000 | $39.40 |
| 17 | 2016 - Q3 (2016-09-30) | $15,658,000 | 5.79% | 410,000 | $40.13 |
| 18 | 2016 - Q2 (2016-06-30) | $17,158,000 | 6.54% | 410,000 | $41.00 |
| 19 | 2016 - Q1 (2016-03-31) | $16,488,000 | 5.35% | 410,000 | $40.18 |
| 20 | 2015 - Q4 (2015-12-31) | $17,486,000 | 3.74% | 410,000 | $46.01 |
| 21 | 2015 - Q3 (2015-09-30) | $19,468,000 | 6.68% | 410,000 | $50.92 |
| 22 | 2015 - Q2 (2015-06-30) | $20,302,000 | 6.2% | 410,000 | $50.68 |
| 23 | 2015 - Q1 (2015-03-31) | $20,272,000 | 5.32% | 410,000 | $47.81 |
| 24 | 2014 - Q4 (2014-12-31) | $18,707,000 | 4.89% | 410,000 | $48.52 |
| 25 | 2014 - Q3 (2014-09-30) | $25,953,000 | 6.57% | 410,000 | $53.71 |
| 26 | 2014 - Q2 (2014-06-30) | $23,272,000 | 6.38% | 410,000 | $53.08 |
| 27 | 2014 - Q1 (2014-03-31) | $21,435,000 | 5.92% | 410,000 | $50.62 |
| 28 | 2013 - Q4 (2013-12-31) | $21,988,000 | 6.24% | 410,000 | $51.60 |
| 29 | 2013 - Q3 (2013-09-30) | $20,758,000 | 1.14% | 410,000 | $50.88 |
| 30 | 2013 - Q2 (2013-06-30) | $21,119,000 | 5.69% | 2,050,000 | $53.28 |
| 31 | 2013 - Q1 (2013-03-31) | $20,943,000 | 5.5% | 2,050,000 | $48.52 |
| 32 | 2012 - Q4 (2012-12-31) | $19,426,000 | 5.08% | 2,050,000 | $44.83 |
| 33 | 2012 - Q3 (2012-09-30) | $17,655,000 | 4.45% | 2,050,000 | $40.78 |
| 34 | 2012 - Q1 (2012-03-31) | $15,888,000 | 3.86% | 2,050,000 | $37.32 |
| 35 | 2011 - Q4 (2011-12-31) | $14,981,000 | 4.23% | 2,050,000 | $34.51 |
| 36 | 2011 - Q3 (2011-09-30) | $13,448,000 | 3.51% | 2,050,000 | $35.90 |
| 37 | 2011 - Q2 (2011-06-30) | $16,470,000 | 3.72% | 2,050,000 | $38.07 |
| 38 | 2011 - Q1 (2011-03-31) | $14,440,000 | 3.54% | 2,050,000 | $34.24 |
| 39 | 2010 - Q4 (2010-12-31) | $13,214,000 | 2.59% | 2,050,000 | $33.56 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
5.0000:1.0000 on 2013-09-30
-
10.0000:1.0000 on 2010-11-17